METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
2022 · Cellular & Molecular Biology Letters · 144 citations
https://doi.org/10.1186/s11658-022-00342-8
M
Meiting Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
1.4K
Citations
18
h-index
33
i10-index
Meiting Chen is an academic researcher from Foshan University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Cancer-related molecular mechanisms research & Viral-associated cancers and disorders. The author has an h-index of 18, co-authored 98 publications.
ORCID: 0000-0002-7195-1300Papers by this author
worksHER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
2023 · Cancer Immunology Immunotherapy · 40 citations
https://doi.org/10.1007/s00262-023-03419-1
Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance
2024 · The Oncologist · 32 citations
https://doi.org/10.1093/oncolo/oyae055
Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis
2024 · Cell Communication and Signaling · 27 citations
https://doi.org/10.1186/s12964-024-01746-z
Insulin-like growth factor binding protein-1 regulates HIF-1α degradation to inhibit apoptosis in hypoxic cardiomyocytes
2021 · Cell Death Discovery · 18 citations
https://doi.org/10.1038/s41420-021-00629-3
HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity
2021 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-021-04035-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat